Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Privia Health Group, Inc.
PRVA
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $3.4B
$27.36
▲ +1.79%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$18.77 - $27.52
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 22.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated multi-stakeholder platform connecting physicians, payers, and health systems
- Proprietary technology and data analytics enabling practice optimization and population health management
- Scale and network effects from serving thousands of independent physicians across the United States
- Established relationships with major health plans and health systems creating switching costs
- Dual revenue model from both providers and payers generating diversified income streams
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Stable outlook
Accelerating shift toward value-based care models rewarding quality and efficiency over volume
Value
Extreme premium - high expectations embedded
Momentum
Hot
+26.7% over 3m
Quality
Thin
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying PRVA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of $0.02 vs $0.08 consensus (-75.0% surprise). Revenue of $603.8M vs $561.0M expected (+7.6%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-75.0%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
+5%
+16%
+23%
+33%
+17%
+26%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$422.3M
$437.9M
$460.9M
$480.1M
$521.2M
$580.4M
$541.2M
$603.8M
Margins · last 8Q
Gross
—
Operating
—
Profit
0.5%
Wall Street consensus
5 analysts · 80% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
80%
Hold
20%
Sell
0%
Median Price Target
$25.00
▼ -8.6% vs $27.36
Latest: Barclays · $24.00 · May 26, 2026
2 analysts covering